Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'tranylcypromine 2 pcpa hcl'

Search results for: 'tranylcypromine 2 pcpa hcl'

Items 1-10 of 58

Page
per page
  1. PF-562271 HCl
    A8345 PF-562271 HCl
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor
      ≥26.35 mg/mL
  2. FIIN-2
    A8696 FIIN-2
    Target: FGFR
    Summary: Irreversible inhibitor of FGFR
      ≥31.75 mg/mL
  3. PD153035 hydrochloride
    A8199 PD153035 hydrochloride
     1 Citation
    Target: EGFR
    Summary: Potent EGFR inhibitor
      insoluble in EtOH; insoluble in H2O; ≥3.97 mg/mL
  4. LRRK2-IN-1
    A3558 LRRK2-IN-1
     1 Citation
    Target: LRRK2|DCLK2
    Summary: LRRK2 inhibitor,cell-permeable and ATP competitive
      ≥28.55 mg/mL
  5. Golvatinib (E7050)
    B1439 Golvatinib (E7050)
    Target: VEGFR
    Summary: C-Met/VEGFR-2 inhibitor
  6. AC480 (BMS-599626)
    A2822 AC480 (BMS-599626)
    Target: EGFR
    Summary: HER1/2 inhibitor,selective and efficacious
      ≥28.35 mg/mL
  7. GW441756
    B2297 GW441756
     1 Citation
    Target: Trk Receptors
    Summary: TrkA inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥13.75 mg/mL
  8. Lapatinib
    A8218 Lapatinib
     2 Citation
    Target: ErbB
    Summary: EGFR/HER2 inhibitor,potent,selective and reversible
      ≥29.05 mg/mL
  9. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: IGF-IR/IR/ALK inhibitor, ATP-competitive
      ≥26.65 mg/mL
  10. Afatinib (BIBW2992)
    A8247 Afatinib (BIBW2992)
     1 Citation
    Target: EGFR
    Summary: Irreversible EGFR/HER2 inhibitor
      ≥24.3 mg/mL

Items 1-10 of 58

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 1 item
  2. Axl 1 item
  3. ALK 2item
  4. c-FMS 1 item
  5. c-Kit 1 item
  6. c-MET 6item
  7. c-RET 1 item
  8. CSF-1R 1 item
  9. EGFR 11item
  10. FAK 3item
  11. FGFR 4item
  12. HER2 5item
  13. LRRK2 4item
  14. PDGFR 6item
  15. Pyk2 2item
  16. Spleen Tyrosine Kinase (Syk) 2item
  17. Src 2item
  18. Tie-2 2item
  19. Trk 1 item
  20. VEGFR 18item
Specificity
  1. Selective 43item
Reversibility
  1. Reversible 6item
  2. Irreversible 4item
Target
  1. Raf 4item
  2. CSF-1R 1 item
  3. FLT3 4item
  4. Eph Receptors 1 item
  5. VEGFR 24item
  6. PDGFR 7item
  7. c-Kit 5item
  8. RET 2item
  9. Bcr-Abl 1 item
  10. FGFR 7item
  11. MET 4item
  12. Src 1 item
  13. Trk Receptors 2item
  14. EGFR 10item
  15. FAK 3item
  16. BMP and Other Activin Receptors 1 item
  17. Syk 2item
  18. ErbB 2item
  19. c-MET 2item
  20. Pyk2 3item
  21. LRRK2 4item
  22. Insulin and Insulin-like Receptors 1 item
  23. ALK 1 item
  24. Tie-2 3item
  25. Flk-1 1 item
  26. KDR 1 item
  27. Fyn kinase 1 item
  28. c-Fms tyrosine kinase 1 item
  29. Lyn kinase 1 item
  30. ErbB-2 1 item
  31. DCLK2 1 item
  32. Flk1 1 item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Bladder Cancer 3item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 12item
  7. Cancer 42item
  8. Cholangiocarcinoma 1 item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Clear Cell Renal Cell Carcinoma 1 item
  11. Colon Cancer 3item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 7item
  14. Glioblastoma 3item
  15. Glioma 2item
  16. Hepatocellular Carcinoma 2item
  17. Liver Cancer 2item
  18. Lung Cancer 3item
  19. Lung Carcinoma 1 item
  20. Lymphoma 1 item
  21. Melanoma 1 item
  22. Multiple Myeloma 3item
  23. Non-small Cell Lung Cancer 3item
  24. Ovarian Cancer 3item
  25. Pancreatic Cancer 7item
  26. Prostate Cancer 3item
  27. Renal Cancer 1 item
  28. Renal Cell Carcinoma 3item
  29. Thyroid Cancer 3item